MYOSLID and neoplasm: The analysis of cancer-associated fibroblasts (CAFs) across multiple algorithms, including XCELL, TIMER, QUANTISEQ, MPCOUNTER, and EPIC, showed a strong positive correlation between risk scores and CAFs, suggesting MYOSLID promotes stromal remodeling to support tumor growth [2].